Ronald Rapoport, MD
Rheumatology · Fall River, MANPI 1336154764
Payments from drug & device makers
Across 823 payments — averaging $410.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$90K
- Amgen$82K
- Pfizer$70K
- GSK$29K
- Novartis$24K
- UCB, Inc.$11K
- plus $31K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 184 | $89,947 |
| Amgen | 168 | $82,077 |
| Pfizer | 92 | $70,381 |
| GSK | 46 | $28,598 |
| Novartis | 55 | $24,104 |
| UCB, Inc. | 24 | $11,256 |
| AbbVie | 109 | $9,562 |
| Sanofi | 16 | $9,248 |
| Regeneron Healthcare Solutions, Inc. | 31 | $8,416 |
| Sobi, Inc | 7 | $1,705 |
| AstraZeneca(2 entities) | 38 | $749 |
| Pacira Pharmaceuticals Incorporated | 1 | $300 |
| Mallinckrodt Hospital Products Inc. | 9 | $280 |
| E.r. Squibb & Sons, L.L.C. | 5 | $170 |
| Johnson & Johnson | 7 | $149 |
| Genentech USA, Inc. | 3 | $128 |
| Cardinal Health 110 LLC | 1 | $100 |
| Medexus Pharma, Inc. | 6 | $93 |
| Sandoz | 4 | $89 |
| Radius Health, Inc. | 3 | $76 |
| Organon | 4 | $59 |
| Merck | 3 | $34 |
| Hikma Pharmaceuticals USA | 1 | $22 |
| Aurinia Pharma U.S., Inc. | 1 | $21 |
| Zyla Life Sciences, Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Pacira Therapeutics, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $14 |
| Avion Pharmaceuticals | 1 | $12 |
How this compares
$337,642 in reported general payments places this provider in the 85th percentile of 265 rheumatology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Fall River
- John StoneBoston$7.1M
- Sebastian UnizonyBoston$4M
- Tuhina NeogiBoston$3.7M
- George TsokosBoston$3.1M
- Roberto CaricchioWorcester$2.8M
- Charles BirbaraWorcester$2.3M
- Tanya LaidlawBoston$1.7M
- Deepak RaoBoston$1.7M
- Katherine LiaoBoston$1.7M
- Peter NigrovicBoston$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.